Trial Summary
What is the purpose of this trial?This clinical trial develops a chatbot smartphone application (app), QuitBot, and text messaging to help American Indians (AI) and Alaska Natives (AN) to quit smoking commercial tobacco (smoking cessation), and evaluates two remote smoking cessation programs to see how well they work for helping AI/AN people quit smoking commercial tobacco. AI/AN populations have one of the highest rates of commercial cigarette smoking of any racial and ethnic group in the United States (US). They also have a higher rate of developing smoking-related cancer but are less likely to quit smoking. The two programs are designed to provide personalized support in setting a smoking cessation goal, tasks to reach the smoking cessation goal, and motivation to remain smoke-free. This may help to keep participants engaged and support them in their quit efforts, and may improve smoking cessation among AI and AN.
Eligibility Criteria
This trial is for American Indians and Alaska Natives who are looking to quit smoking. It's designed to help them with personalized support through a smartphone app called QuitBot and text messaging programs.Inclusion Criteria
Smoking combustible cigarettes daily in the past year
I want to learn how to quit smoking.
Ability to read English
+13 more
Exclusion Criteria
Pregnant or breastfeeding
Use of other tobacco products (e.g., ceremonial use of tobacco, e-cigarettes) will be assessed but is not an exclusion criterion, as it would limit the study's generalizability
Participant Groups
The study tests two remote smoking cessation methods: the QuitBot app and a text messaging program. Both aim to provide motivation, support in setting goals, tasks for quitting smoking, and maintaining a smoke-free life.
2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I (QuitBot chatbot)Experimental Treatment4 Interventions
Participants participate in the QuitBot program which involves chatbot messages over 42 days. Therapy description withheld to protect the integrity of the study.
Group II: Arm II (QuitBot texting)Active Control4 Interventions
Participants participate in the QuitBot program which involves text messages over 42 days. Therapy description withheld to protect the integrity of the study.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Fred Hutch/University of Washington Cancer ConsortiumSeattle, WA
Loading ...
Who Is Running the Clinical Trial?
Fred Hutchinson Cancer CenterLead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)Collaborator